Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds are disclosed that are represented by general formula (I). Also disclosed, are pharmaceutical compositions including these compounds and methods of using these compounds and compositions for the treatment of chemokine-mediated pathologies.
本文披露了通式(I)所代表的二取代
3,4-二氨基-3-环丁烯-1,2-二酮化合物。此外,本文还披露了包括这些化合物的制药组合物以及使用这些化合物和组合物治疗
趋化因子介导的病理状况的方法。